| Code |
| PEVE |
| Title |
| PT Penta Valent Tbk |
| Address |
|
| Background |
The Company is primarily engaged in distribution pharmaceutical products, medical equipment and consumer products. |
| Business cp product |
The Company is primarily engaged in distribution pharmaceutical products, medical equipment and consumer products. |
| Subsidiary affiliation |
|
| Commissioners |
| President Commissioner | : Hermanto Tanoko | | | Commissioner | : Nobertus Rahardjo Muljono | | | Independent Commissioner | : Drs. Mohammad Raylan, MM | | | | | | Per 30 Sep 2023 | | |
|
| Directors |
| President Director | : Sukismo | | | Director | : Franxiscus Afat Adinata Nursalim | | | Director | : Melisa Patricia | | | | | | Per 30 Sep 2023 | | |
|
| Underwriter |
| PT. Lotus Andalan Sekuritas | |
| Share registrar |
|
| Share holders |
| Shareholders | Shares | % | | | | PT Tancorp Mega Buana | 988750000 | 56 | | | | PT Maramakmur Selaras | 216112500 | 12.24 | | | | PT Multi Pidotama Mandiri | 207637500 | 11.76 | | | | Franxiscus Afat Adinata Nursalim | 38850000 | 2.2 | | | | Public | 314275000 | 17.8 | | | | | | | | | As of Sep 30, 2023 | | | | |
|
| History stocks |
Type of ListingDatePrice## of SharesTotal Listed Shares IPO @ Rp 14924-Jan-2023203531250001765625000
|
| Other infos |
|
| Created date |
| 2023-11-23 15:49:53 |
| Revised date |
| 2023-11-23 15:49:53 |
| Finance |
| Financial Statetment Date |
| Fiscal Year Ends |
| Months Covered in Income St |
| |
| Summary Covered in Income St |
| Cash and Cash Equivalents |
| Receivables |
| Inventories |
| Current Assets |
| Fixed Assets |
| Other Assets |
| Non Current Assets |
| Total Assets |
| Current Liabilities |
| Longterm Liabilities |
| Total Liabilities |
| Authorized |
| Paid-up Capital |
| Par Value |
| Paid-up Capital Shares |
| Retained Earnings |
| Total Equity |
| Minority Interest |
| |
| Summary of Income Statement |
| Total Sales |
| Cost of Good Sold |
| Gross Profit |
| Operating Profit |
| Other Income |
| Earning Before Tax |
| Tax |
| Net Income |
| Close Price |
| |
| Per Share Data (Rp) |
| Eps (annualized) |
| Book Value |
| |
| Financial Ratios |
| Debt Equity Ratio (X) |
| Roa(%) |
| Roe(%) |
| Npm(%) |
| Opm(%) |
| Gross Profit Margin (%) |
| Total Assets Turnover |
| |
| Cash Flow |
| CF from Operation Activities |
| CF from Investing Activities |
| CF from Financing Activities |
| Net Increase in Cash & Cash Equivalent |
| Cash & Cash Equivalent at Beginning of the Year |
| Cash & Cash Equivalent at The End of the Year |
|
|